PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 21-Strain pneumonia vaccine shows promise in infant trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine (PCV21) that protects against 21 types of pneumonia-causing bacteria. About 1,700 healthy infants will receive either the new vaccine or an existing one alongside their routine shots. The goal is to see if the new vaccine is safe and helps babies bu…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New vaccine targets 21 pneumonia strains in infant trial
⭐️ VACCINE ⭐️ OngoingThis phase 3 study tests whether a new 21-valent pneumococcal vaccine (PCV21) is safe for healthy infants. About 2360 babies will receive either PCV21 or the current Prevnar 20 vaccine at 2, 4, 6, and 12-15 months old. Researchers will monitor for side effects like injection-site…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
New 21-Valent vaccine aims to shield babies from pneumonia and meningitis
⭐️ VACCINE ⭐️ OngoingThis study tests a new 21-valent pneumococcal conjugate vaccine (PCV21) in about 1,092 healthy infants and toddlers. The goal is to see if PCV21 is safe and helps the body produce antibodies against pneumococcal bacteria better than the current licensed vaccine. Participants rece…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine combo could simplify infant shots
⭐️ VACCINE ⭐️ OngoingThis Phase 3 study tests whether mixing a new 21-valent pneumococcal vaccine with a licensed 20-valent version is safe and helps build immunity in healthy infants. About 580 babies will receive different combinations of the vaccines at routine checkups. The goal is to see if flex…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:04 UTC